Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Published 27/12/2023, 19:11
Updated 27/12/2023, 20:40
© Reuters.  Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.

Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases.
  • Cingulate Inc. (NASDAQ: CING) gained 95.2% to $4.08.
  • RiskOn International, Inc. (NASDAQ: ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024.
  • Cytokinetics, Incorporated (NASDAQ: CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
  • AEye, Inc. (NASDAQ: LIDR) rose 61.2% to $3.58.
  • Vince Holding Corp. (NYSE: VNCE) jumped 42% to $3.2399.
  • Bit Brother Limited(NASDAQ: BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday.
  • Nxu, Inc. (NASDAQ: NXU) rose 34% to $4.18.
  • Virax Biolabs Group Limited (NASDAQ: VRAX) gained 32% to $1.7551.
  • Jet.AI Inc. (NASDAQ: JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday.
  • Elicio Therapeutics, Inc. (NASDAQ: ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81.
  • Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) gained 24.7% to $0.2518 after the company announced results from a series of in vivo studies demonstrating oral delivery of two LNC-formulated small single-strand oligonucleotides.
  • Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 23.8% to $2.70 after the company reported the FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.
  • TeraWulf Inc. (NASDAQ: WULF) gained 21.3% to $2.6950 after gaining 3% on Tuesday.
  • Jiuzi Holdings, Inc. (NASDAQ: JZXN) rose 15.2% to $0.7322.
  • Burford Capital Limited (NYSE: BUR) gained 14.3% to $15.44.
  • Edgewise Therapeutics, Inc. (NASDAQ: EWTX) climbed 13.8% to $10.84.
  • Mobile Global Esports Inc. (NASDAQ: MGAM) shares rose 13.8% to $0.4380 after gaining 33% on Tuesday.
  • Wheels Up Experience Inc. (NYSE: UP) gained 12.8% to $4.74.
  • Organogenesis Holdings Inc. (NASDAQ: ORGO) surged 12.2% to $4.4550. BTIG maintained Organogenesis with a Buy and raised the price target from $4 to $6.
  • Ascent Industries Co. (NASDAQ: ACNT) rose 11.9% to $9.05 as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal.
  • Mynd.ai, Inc. (NYSE: MYND) gained 10.4% to $5.20.
  • Coinbase Global, Inc. (NASDAQ: COIN) surged 7.4% to $184.89.
  • Li Auto Inc. (NASDAQ: LI) gained 5.1% to $36.20.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Hallmark Financial Services, Inc. (NASDAQ: HALL) shares fell 31.4% to $1.0764. Hallmark Financial Services gave notice to Nasdaq of intention to voluntarily delist its shares of common stock from Nasdaq Global Market.
  • Baosheng Media Group Holdings Limited (NASDAQ: BAOS) fell 29.5% to $4.1050.
  • Nukkleus Inc. (NASDAQ: NUKK) shares fell 28.8% to $2.60 after jumping around 11% on Tuesday.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) fell 20.4% to $7.07 after the FDA placed a clinical hold on the IOV-LUN-202 trial in response to a recently reported Grade 5 adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.
  • Mobix Labs, Inc. (NASDAQ: MOBX) shares fell 17.1% to $5.80 after surging over 34% on Tuesday.
  • Color Star Technology Co., Ltd. (NASDAQ: ADD) dipped 15.4% to $0.33.
  • Bluejay Diagnostics, Inc. (NASDAQ: BJDX) fell 15.4% to $2.20. Bluejay Diagnostics announced initiation of multicenter clinical study evaluating symphony IL-6 in sepsis patients.
  • Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) declined 15% to $0.7880.
  • ARB IOT Group Limited (NASDAQ: ARBB) fell 14.4% to $2.2155 after surging 175% on Tuesday.
  • Asset Entities Inc. (NASDAQ: ASST) declined 13.7% to $0.6120.
  • Volcon, Inc. (NASDAQ: VLCN) fell 12.7% to $0.1224. On Dec 19, Volcon got deficiency letter from Nasdaq that the company did not meet minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
  • Smart for Life, Inc. (NASDAQ: SMFL) shares fell 10.8% to $1.63 after declining 7% on Tuesday.
  • Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 9.1% to $0.2090. Brainstorm Cell Therapeutics shares gained 16% on Tuesday after the company announced that it was granted patents for Allogeneic Exosome Platform-Product in neurological disorder treatments.
  • Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares fell 8.7% to $1.16. Inspira Technologies shares gained 5% on Tuesday after the company announced 95% accuracy results for HYLA Blood Sensor. Additionally, the company plans FDA submission for clearance in 2024.
  • InnSuites Hospitality Trust (NYSE: IHT) fell 8.6% to $1.4250.
  • Oncternal Therapeutics, Inc. (NASDAQ: ONCT) shares fell 6.8% to $0.5510. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.
  • Canopy Growth Corporation (NASDAQ: CGC) fell 6.2% to $5.31.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Amazon, Adobe And 2 Other Stocks Insiders Are Selling

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.